Your browser doesn't support javascript.
loading
Recurrence Score® Result Impacts Treatment Decisions in Hormone Receptor-Positive, HER2-Negative Patients with Early Breast Cancer in a Real-World Setting-Results of the IRMA Trial.
Dannehl, Dominik; Engler, Tobias; Volmer, Lea L; Staebler, Annette; Fischer, Anna K; Weiss, Martin; Hahn, Markus; Walter, Christina B; Grischke, Eva-Maria; Fend, Falko; Taran, Florin-Andrei; Brucker, Sara Y; Hartkopf, Andreas D.
Afiliação
  • Dannehl D; Department for Womens' Health, Tuebingen University, 72076 Tübingen, Germany.
  • Engler T; Department for Womens' Health, Tuebingen University, 72076 Tübingen, Germany.
  • Volmer LL; Department for Womens' Health, Tuebingen University, 72076 Tübingen, Germany.
  • Staebler A; Department for Pathology and Neuropathology, Tuebingen University, 72076 Tübingen, Germany.
  • Fischer AK; Department for Pathology and Neuropathology, Tuebingen University, 72076 Tübingen, Germany.
  • Weiss M; Department for Womens' Health, Tuebingen University, 72076 Tübingen, Germany.
  • Hahn M; Department for Womens' Health, Tuebingen University, 72076 Tübingen, Germany.
  • Walter CB; Department for Womens' Health, Tuebingen University, 72076 Tübingen, Germany.
  • Grischke EM; Department for Womens' Health, Tuebingen University, 72076 Tübingen, Germany.
  • Fend F; Department for Pathology and Neuropathology, Tuebingen University, 72076 Tübingen, Germany.
  • Taran FA; Department for Gynecology and Obstetrics, Freiburg University, 79085 Freiburg im Breisgau, Germany.
  • Brucker SY; Department for Womens' Health, Tuebingen University, 72076 Tübingen, Germany.
  • Hartkopf AD; Department for Womens' Health, Tuebingen University, 72076 Tübingen, Germany.
Cancers (Basel) ; 14(21)2022 Oct 31.
Article em En | MEDLINE | ID: mdl-36358784

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha